Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$2.95 - $4.44 $590 - $888
-200 Reduced 6.31%
2,969 $11,000
Q3 2022

Nov 07, 2022

SELL
$0.48 - $3.48 $14 - $107
-31 Reduced 0.97%
3,169 $8,000
Q4 2020

Feb 03, 2021

BUY
$8.21 - $18.59 $1,642 - $3,718
200 Added 6.67%
3,200 $27,000
Q1 2018

May 14, 2018

BUY
$4.91 - $7.72 $14,730 - $23,160
3,000 New
3,000 $17,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.57B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.